Steven Cohen Surmodics Inc Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$17.67 - $31.31 $158,623 - $281,069	-8,977 Reduced 84.25%	1,678 $52,000
Q1 2023 May 15, 2023	BUY	$17.13 - $38.52 $182,520 - $410,430	10,655 New	10,655 $242,000
Q2 2022 Aug 15, 2022	SELL	$33.25 - $45.11 $19,950 - $27,066	-600 Reduced 4.96%	11,500 $428,000
Q1 2022 May 16, 2022	SELL	$40.68 - $49.72 $435,235 - $531,954	-10,699 Reduced 46.93%	12,100 $548,000
Q4 2021 Feb 14, 2022	BUY	$43.21 - $57.6 $985,144 - $1.31 Million	22,799 New	22,799 $1.1 Million

124

13.2M

25.5K

3.4K

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $539M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.